Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis

BACKGROUND: Docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy can cause severe adverse events, including neutropenia and febrile neutropenia. The feasibility of DCF therapy is a concern, particularly for elderly patients, patients with moderate organ disorders, and patients suffering from malnu...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Yuji, Sasaki, Akira, Endo, Fumitaka, Nikai, Haruka, Amano, Satoshi, Umemura, Akira, Baba, Shigeaki, Chiba, Takehiro, Kimura, Toshimoto, Takahara, Takeshi, Nitta, Hiroyuki, Otsuka, Koki, Mizuno, Masaru, Kimura, Yusuke, Koeda, Keisuke, Iwaya, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027574/
https://www.ncbi.nlm.nih.gov/pubmed/29966526
http://dx.doi.org/10.1186/s12957-018-1420-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027574/
https://www.ncbi.nlm.nih.gov/pubmed/29966526
http://dx.doi.org/10.1186/s12957-018-1420-8

Ejemplares similares